According to the company, certain FDA-approved GLP-1/GIP medications may be eligible for insurance coverage, and the company states it assists with prior authorizations but does not bill insurance directly
Tirzepatide 15 mg (Mounjaro/Zepbound) produced 22.5% mean weight loss at 72 weeks in SURMOUNT-1 (N=2,539) [14]
The long-term efficacy and maintenance of weight loss with Semaglutide GLP-1 are still under investigation
Besides price, notes Scherr, an advantage is the minimizing of side effects, one of the key detractors for people adhering to GLP-1 use. Back in April, Noom was campaigning for new rules that would in essence allow it to keep selling compounded GLP-1s -- despite the FDAs no longer allowing such sales
Your body is changing quickly, and that can feel unsettling
DPP-4 inhibitors carry a minimal risk of hypoglycemia and gastrointestinal symptoms